133 related articles for article (PubMed ID: 26855561)
1. Effects of probenecid and cimetidine on the pharmacokinetics of nemonoxacin in healthy Chinese volunteers.
Zhang YF; Dai XJ; Yang Y; Chen XY; Wang T; Tang YB; Tsai CY; Chang LW; Chang YT; Zhong DF
Drug Des Devel Ther; 2016; 10():357-70. PubMed ID: 26855561
[TBL] [Abstract][Full Text] [Related]
2. Safety and clinical pharmacokinetics of nemonoxacin, a novel non-fluorinated quinolone, in healthy Chinese volunteers following single and multiple oral doses.
Guo B; Wu X; Zhang Y; Shi Y; Yu J; Cao G; Zhang J
Clin Drug Investig; 2012 Jul; 32(7):475-86. PubMed ID: 22650326
[TBL] [Abstract][Full Text] [Related]
3. Effects of an Al(3+)- and Mg(2+)-containing antacid, ferrous sulfate, and calcium carbonate on the absorption of nemonoxacin (TG-873870) in healthy Chinese volunteers.
Zhang YF; Dai XJ; Wang T; Chen XY; Liang L; Qiao H; Tsai CY; Chang LW; Huang PT; Hsu CY; Chang YT; Tsai CE; Zhong DF
Acta Pharmacol Sin; 2014 Dec; 35(12):1586-92. PubMed ID: 25327812
[TBL] [Abstract][Full Text] [Related]
4. Coadministration of probenecid and cimetidine with mirogabalin in healthy subjects: A phase 1, randomized, open-label, drug-drug interaction study.
Tachibana M; Yamamura N; Atiee GJ; Hsu C; Warren V; He L; Dishy V; Zahir H
Br J Clin Pharmacol; 2018 Oct; 84(10):2317-2324. PubMed ID: 29920736
[TBL] [Abstract][Full Text] [Related]
5. Population Pharmacokinetics Study of Nemonoxacin Among Chinese Patients With Moderate Hepatic Impairment.
Kang Y; Li Y; Xu F; Zhang J; Wang K; Chen Y; Wu J; Guo B; Yu J; Zhang Y
Clin Ther; 2019 Mar; 41(3):505-517.e0. PubMed ID: 30819510
[TBL] [Abstract][Full Text] [Related]
6. Effects of Nemonoxacin on Thorough ECG QT/QTc Interval: A Randomized, Placebo- and Positive-controlled Crossover Study in Healthy Chinese Adults.
Zhao C; Lv Y; Li X; Hou F; Ma X; Wei M; Kang Z; Cui L; Xia Y; Liu Y; Tian J
Clin Ther; 2018 Jun; 40(6):983-992. PubMed ID: 29803534
[TBL] [Abstract][Full Text] [Related]
7. Effect of cimetidine and probenecid on pilsicainide renal clearance in humans.
Shiga T; Hashiguchi M; Urae A; Kasanuki H; Rikihisa T
Clin Pharmacol Ther; 2000 Mar; 67(3):222-8. PubMed ID: 10741624
[TBL] [Abstract][Full Text] [Related]
8. Different effects of three transporting inhibitors, verapamil, cimetidine, and probenecid, on fexofenadine pharmacokinetics.
Yasui-Furukori N; Uno T; Sugawara K; Tateishi T
Clin Pharmacol Ther; 2005 Jan; 77(1):17-23. PubMed ID: 15637527
[TBL] [Abstract][Full Text] [Related]
9. Dose escalation study of the safety, tolerability, and pharmacokinetics of nemonoxacin (TG-873870), a novel potent broad-spectrum nonfluorinated quinolone, in healthy volunteers.
Lin L; Chang LW; Tsai CY; Hsu CH; Chung DT; Aronstein WS; Ajayi F; Kuzmak B; Lyon RA
Antimicrob Agents Chemother; 2010 Jan; 54(1):405-10. PubMed ID: 19884368
[TBL] [Abstract][Full Text] [Related]
10. Multiple interactions of cimetidine and probenecid with valaciclovir and its metabolite acyclovir.
De Bony F; Tod M; Bidault R; On NT; Posner J; Rolan P
Antimicrob Agents Chemother; 2002 Feb; 46(2):458-63. PubMed ID: 11796358
[TBL] [Abstract][Full Text] [Related]
11. Neither cimetidine nor probenecid affect the pharmacokinetics of tenoxicam in normal volunteers.
Day RO; Geisslinger G; Paull P; Williams KM
Br J Clin Pharmacol; 1994 Jan; 37(1):79-81. PubMed ID: 8148224
[TBL] [Abstract][Full Text] [Related]
12. Multiple-dose safety, tolerability, and pharmacokinetics of oral nemonoxacin (TG-873870) in healthy volunteers.
Chung DT; Tsai CY; Chen SJ; Chang LW; King CH; Hsu CH; Chiu KM; Tan HC; Chang YT; Hsu MC
Antimicrob Agents Chemother; 2010 Jan; 54(1):411-7. PubMed ID: 19884374
[TBL] [Abstract][Full Text] [Related]
13. Safety, tolerability, and pharmacokinetics of intravenous nemonoxacin in healthy chinese volunteers.
Cao GY; Zhang J; Zhang YY; Guo BN; Yu JC; Wu XJ; Chen YC; Wu JF; Shi YG
Antimicrob Agents Chemother; 2014 Oct; 58(10):6116-21. PubMed ID: 25092690
[TBL] [Abstract][Full Text] [Related]
14. Pharmacokinetic properties and bioequivalence of two compound formulations of 1500 mg ampicillin (1167 mg)/probenecid (333 mg): a randomized-sequence, single-dose, open-label, two-period crossover study in healthy Chinese male volunteers.
Wu H; Liu M; Wang S; Feng W; Yao W; Zhao H; Wei M
Clin Ther; 2010 Mar; 32(3):597-606. PubMed ID: 20399996
[TBL] [Abstract][Full Text] [Related]
15. Pharmacokinetics and pharmacodynamics of multiple-dose intravenous nemonoxacin in healthy Chinese volunteers.
Wu XJ; Zhang J; Guo BN; Zhang YY; Yu JC; Cao GY; Chen YC; Zhu DM; Ye XY; Wu JF; Shi YG; Chang LW; Chang YT; Tsai CY
Antimicrob Agents Chemother; 2015 Mar; 59(3):1446-54. PubMed ID: 25534726
[TBL] [Abstract][Full Text] [Related]
16. Validation of a Drug Transporter Probe Cocktail Using the Prototypical Inhibitors Rifampin, Probenecid, Verapamil, and Cimetidine.
Wiebe ST; Giessmann T; Hohl K; Schmidt-Gerets S; Hauel E; Jambrecina A; Bader K; Ishiguro N; Taub ME; Sharma A; Ebner T; Mikus G; Fromm MF; Müller F; Stopfer P
Clin Pharmacokinet; 2020 Dec; 59(12):1627-1639. PubMed ID: 32504272
[TBL] [Abstract][Full Text] [Related]
17. Effects of rifampicin and cimetidine on pharmacokinetics and pharmacodynamics of lamotrigine in healthy subjects.
Ebert U; Thong NQ; Oertel R; Kirch W
Eur J Clin Pharmacol; 2000 Jul; 56(4):299-304. PubMed ID: 10954343
[TBL] [Abstract][Full Text] [Related]
18. Safety and pharmacokinetics of dicloxacillin in healthy Chinese volunteers following single and multiple oral doses.
Wu G; Zheng Y; Zhou H; Hu X; Liu J; Zhai Y; Zhu M; Wu L; Shentu J
Drug Des Devel Ther; 2015; 9():5687-95. PubMed ID: 26527863
[TBL] [Abstract][Full Text] [Related]
19. N
Müller F; Hohl K; Keller S; Schmidt-Gerets S; Deutsch B; Schuler-Metz A; Fromm MF; Stopfer P; Gessner A
Clin Pharmacol Ther; 2023 May; 113(5):1070-1079. PubMed ID: 36636898
[TBL] [Abstract][Full Text] [Related]
20. Pharmacokinetics of alogliptin when administered with food, metformin, or cimetidine: a two-phase, crossover study in healthy subjects.
Karim A; Covington P; Christopher R; Davenport M; Fleck P; Li X; Wann E; Mekki Q
Int J Clin Pharmacol Ther; 2010 Jan; 48(1):46-58. PubMed ID: 20040339
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
